{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:36:26Z","timestamp":1791902186997,"version":"4.3.4"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The role of non-nitrogen-containing bisphosphonates (non-N-BPs) and nitrogen-containing bisphosphonates (N-BPs) in the treatment of atherosclerosis (AS) and vascular calcification (VC) is uncertain. This meta-analysis was conducted to evaluate the efficacy of non-N-BPs and N-BPs in the treatment of AS and VC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, and Wanfang databases were searched from their inception to July 5th, 2023. Eligible studies comparing bisphosphonates (BPs) versus no BPs in the treatment of AS and VC were included. The data were analyzed using Review Manager Version 5.3.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Seventeen studies were included in this meta-analysis. Twelve were randomized control trials (RCTs), and 5 were nonrandomized studies. Overall, 813 patients were included in the BPs group, and 821 patients were included in the no BPs group. Compared with no BP treatment, non-N-BP or N-BP treatment did not affect serum calcium (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05), phosphorus (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05) or parathyroid hormone (PTH) levels (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05). Regarding the effect on serum lipids, non-N-BPs decreased the serum total cholesterol (TC) level (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05) and increased the serum triglyceride (TG) level (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01) but did not affect the serum low-density lipoprotein cholesterol (LDL-C) level (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05). N-BPs did not affect serum TC (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05), TG (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05) or LDL-C levels (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05). Regarding the effect on AS, non-N-BPs did not have a beneficial effect (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05). N-BPs had a beneficial effect on AS, including reducing the intima-media thickness (IMT) (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05) and plaque area (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01). For the effect on VC, non-N-BPs had a beneficial effect (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01), but N-BPs did not have a beneficial effect (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Non-N-BPs and N-BPs did not affect serum calcium, phosphorus or PTH levels. Non-N-BPs decreased serum TC levels and increased serum TG levels. N-BPs did not affect serum lipid levels. Non-N-BPs had a beneficial effect on VC, and N-BPs had a beneficial effect on AS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000038404","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T14:12:08Z","timestamp":1717769528000},"page":"e38404","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Non-nitrogen-containing bisphosphonates and nitrogen-containing bisphosphonates for the treatment of atherosclerosis and vascular calcification: A meta-analysis"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1190-0955","authenticated-orcid":false,"given":"Wei","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Nephrology, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu, China"},{"name":"Department of Nephrology, The Wujin Clinical College of Xuzhou Medical University, Changzhou, Jiangsu, China"},{"name":"Department of Nephrology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China"},{"name":"Department of Nephrology, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyuan","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu, China"},{"name":"Department of Nephrology, The Wujin Clinical College of Xuzhou Medical University, Changzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weigang","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu, China"},{"name":"Department of Nephrology, The Wujin Clinical College of Xuzhou Medical University, Changzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu, China"},{"name":"Department of Nephrology, The Wujin Clinical College of Xuzhou Medical University, Changzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu, China"},{"name":"Department of Nephrology, The Wujin Clinical College of Xuzhou Medical University, Changzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu, China"},{"name":"Department of Nephrology, The Wujin Clinical College of Xuzhou Medical University, Changzhou, Jiangsu, China"},{"name":"Department of Nephrology, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41419-022-04923-5","article-title":"Programmed cell death in atherosclerosis and vascular calcification.","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/cvr\/cvy010","article-title":"Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness.","volume":"114","author":"Durham","year":"2018","journal-title":"Cardiovasc Res"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/S0100-879X2007000400001","article-title":"Bone metabolism and vascular calcification.","volume":"40","author":"Danilevicius","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0002-9343(99)00028-5","article-title":"The association between low bone mass at the menopause and cardiovascular mortality.","volume":"106","author":"von der Recke","year":"1999","journal-title":"Am J Med"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12020-013-9924-z","article-title":"Should we abandon statins in the prevention of bone fractures?","volume":"44","author":"Esposito","year":"2013","journal-title":"Endocrine"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4137\/CMED.S10007","article-title":"Vascular effects of bisphosphonates-a systematic review.","volume":"5","author":"Santos","year":"2012","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s40265-019-01145-6","article-title":"Current treatments and new developments in the management of glucocorticoid-induced osteoporosis.","volume":"79","author":"Raterman","year":"2019","journal-title":"Drugs"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jsbmb.2013.09.008","article-title":"Prevention and treatment of postmenopausal osteoporosis.","volume":"142","author":"Tella","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ki.2008.646","article-title":"Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.","volume":"75","author":"Lomashvili","year":"2009","journal-title":"Kidney Int"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yjmcc.2016.08.017","article-title":"Vascular action of bisphosphonates: In vitro effect of alendronate on the regulation of cellular events involved in vessel pathogenesis.","volume":"100","author":"Cutini","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1254\/jphs.FPJ05019X","article-title":"Effect of etidronate on aortic calcification and bone metabolism in calcitriol-treated rats with subtotal nephrectomy.","volume":"99","author":"Tamura","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0021-9150(75)90021-0","article-title":"The effect of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis.","volume":"22","author":"Rosenblum","year":"1975","journal-title":"Atherosclerosis"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0021-9150(87)90263-2","article-title":"The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on necrosis of atherosclerotic lesions.","volume":"67","author":"Daoud","year":"1987","journal-title":"Atherosclerosis"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00198-020-05430-z","article-title":"Once-yearly zoledronic acid and change in abdominal aortic calcification over 3 years in postmenopausal women with osteoporosis: results from the HORIZON pivotal fracture trial.","volume":"31","author":"Cai","year":"2020","journal-title":"Osteoporos Int"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/gme.0b013e318194cafd","article-title":"The effect of alendronate sodium on carotid artery intima-media thickness and lipid profile in women with postmenopausal osteoporosis.","volume":"16","author":"Celiloglu","year":"2009","journal-title":"Menopause"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jacc.2017.12.062","article-title":"Etidronate for prevention of ectopic mineralization in patients with pseudoxanthoma elasticum.","volume":"71","author":"Kranenburg","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews.","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1097\/BRS.0000000000001061","article-title":"Updated method guideline for systematic reviews in the Cochrane back and neck group.","volume":"40","author":"Furlan","journal-title":"Spine"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1744-9987.2006.00345.x","article-title":"Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects.","volume":"10","author":"Hashiba","year":"2006","journal-title":"Ther Apher Dial"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S1076-6332(03)80516-0","article-title":"Progression of coronary artery calcification in patients taking alendronate for osteoporosis.","volume":"9","author":"Hill","year":"2002","journal-title":"Acad Radiol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ctr.13131","article-title":"A rapid and sustained improvement of calcification propensity score (serum T50) after successful kidney transplantation: reanalysis of a randomized controlled trial of ibandronate.","volume":"31","author":"Smerud","year":"2017","journal-title":"Clin Transplant"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1526-0968.2004.00136.x","article-title":"Inhibitory effects of etidronate on the progression of vascular calcification in hemodialysis patients.","volume":"8","author":"Hashiba","year":"2004","journal-title":"Ther Apher Dial"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1097\/TP.0b013e3181dc13d0","article-title":"Open-label trial: effect of weekly risedronate immediately after transplantation in kidney recipients.","volume":"89","author":"Torregrosa","year":"2010","journal-title":"Transplantation"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00044011-200626040-00006","article-title":"Effect of etidronic acid on arterial calcification in dialysis patients.","volume":"26","author":"Ariyoshi","year":"2006","journal-title":"Clin Drug Investig"},{"key":"R27-20250503","first-page":"724","article-title":"Effects of zoledronic acid on bloodlipids, carotid IMT and plaque-related indexes in postmenopausal women with atherosclerosis and osteoporosis.","volume":"46","author":"Pu","year":"2020","journal-title":"Jiangsu Med J"},{"key":"R28-20250503","first-page":"544","article-title":"Research on effects of alendronate on atherosclerosis in female postmenopausal patients with osteoporosis.","volume":"20","author":"Chen","year":"2016","journal-title":"Chin J Lab Diagn"},{"key":"R29-20250503","first-page":"86","article-title":"Application value of alendronate sodium in the treatment of postmenopausal osteoporosis complicated with atherosclerosis.","volume":"3","author":"Zuo","year":"2015","journal-title":"Cardiovasc Dis J Integr Tradit Chin West Med"},{"key":"R30-20250503","first-page":"192","article-title":"Effect of alendronate sodium on atherosclerosis in postmenopausal women.","volume":"33","author":"Luo","year":"2014","journal-title":"Chin J Geriatr"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1161\/CIRCULATIONAHA.113.001534","article-title":"Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial.","volume":"127","author":"Kawahara","year":"2013","journal-title":"Circulation"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1359\/jbmr.2000.15.3.599","article-title":"Chronic intravenous amino bisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol.","volume":"15","author":"Adami","year":"2000","journal-title":"J Bone Miner Res"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00223-008-9123-8","article-title":"The effects of zoledronic acid on serum lipids in multiple myeloma patients.","volume":"82","author":"Gozzetti","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"R34-20250503","first-page":"269613","article-title":"Alendronate as an effective treatment for bone loss and vascular calcification in kidney transplant recipients.","volume":"2014","author":"Okamoto","year":"2014","journal-title":"J Transplant"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1093\/ndt\/gfad122","article-title":"Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis.","volume":"38","author":"Mart\u00edn-Carro","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/1573403X14666180619103258","article-title":"Role of bisphosphonates in vascular calcification and bone metabolism: a clinical summary.","volume":"14","author":"Dayanand","year":"2018","journal-title":"Curr Cardiol Rev"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"96","DOI":"10.14310\/horm.2002.1226","article-title":"Bisphosphonate-associated adverse events.","volume":"8","author":"Papapetrou","year":"2009","journal-title":"Hormones (Athens)"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/hr.2013.96","article-title":"Inhibition of farnesyl pyrophosphate synthase prevents norepinephrine-induced fibrotic responses in vascular smooth muscle cells from spontaneously hypertensive rats.","volume":"37","author":"Du","year":"2014","journal-title":"Hypertens Res"},{"issue":"4 Suppl","key":"R39-20250503","first-page":"38","article-title":"Bisphosphonates and atherosclerosis.","volume":"32","author":"Fiore","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2008.10.043","article-title":"Zoledronate inhibits the proliferation, adhesion and migration of vascular smooth muscle cells.","volume":"602","author":"Wu","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.2147\/DDDT.S168897","article-title":"Zoledronate inhibits fibroblasts\u2019 proliferation and activation via targeting TGF-\u03b2 signaling pathway.","volume":"12","author":"Zhao","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jss.2012.10.033","article-title":"Differential effect of zoledronic acid on human vascular smooth muscle cells.","volume":"182","author":"Albadawi","year":"2013","journal-title":"J Surg Res"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"30721","DOI":"10.18632\/oncotarget.10738","article-title":"Etidronate prevents, but does not reverse, ectopic mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6-\/-).","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2006.12.006","article-title":"Prevention of aortic calcification by etidronate in the renal failure rat model.","volume":"558","author":"Tamura","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.nefroe.2018.03.003","article-title":"Role of pyrophosphate in vascular calcification in chronic kidney disease.","volume":"38","author":"Azpiazu","year":"2018","journal-title":"Nefrologia (Engl Ed)"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1253\/circj.CJ-11-0477","article-title":"Calcium phosphate deposition with normal phosphate concentration. Role of pyrophosphate-.","volume":"75","author":"Villa-Bellosta","year":"2011","journal-title":"Circ J"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/sj.ki.5001841","article-title":"Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate.","volume":"70","author":"Price","year":"2006","journal-title":"Kidney Int"},{"key":"R48-20250503","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.ATV.21.5.817","article-title":"Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption.","volume":"21","author":"Price","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R49-20250503","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3892\/mmr.2013.1489","article-title":"Effects of alendronate on the Notch1\u2011RBP\u2011J\u03ba signaling pathway in the osteogenic differentiation and mineralization of vascular smooth muscle cells.","volume":"8","author":"Zhou","year":"2013","journal-title":"Mol Med Rep"},{"key":"R50-20250503","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.121.053708","article-title":"Effect of denosumab or alendronic acid on the progression of aortic stenosis: a double-blind randomized controlled trial.","volume":"143","author":"Pawade","year":"2021","journal-title":"Circulation"},{"key":"R51-20250503","doi-asserted-by":"crossref","first-page":"115751","DOI":"10.1016\/j.bone.2020.115751","article-title":"Is there a role for bisphosphonates in vascular calcification in chronic kidney disease?","volume":"142","author":"Hildebrand","year":"2021","journal-title":"Bone"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:26:10Z","timestamp":1746318370000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":51,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038404","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,7]]}}}